216 related articles for article (PubMed ID: 19324868)
1. Cerebrospinal fluid study in paraneoplastic syndromes.
Psimaras D; Carpentier AF; Rossi C;
J Neurol Neurosurg Psychiatry; 2010 Jan; 81(1):42-5. PubMed ID: 19324868
[TBL] [Abstract][Full Text] [Related]
2. Antigen-specific oligoclonal bands in cerebrospinal fluid and serum from patients with anti-amphiphysin- and anti-CV2/CRMP5 associated paraneoplastic neurological syndromes.
Stich O; Rauer S
Eur J Neurol; 2007 Jun; 14(6):650-3. PubMed ID: 17539943
[TBL] [Abstract][Full Text] [Related]
3. Prostate cancer, Hu antibodies and paraneoplastic neurological syndromes.
Storstein A; Raspotnig M; Vitaliani R; Giometto B; Graus F; Grisold W; Honnorat J; Vedeler CA
J Neurol; 2016 May; 263(5):1001-1007. PubMed ID: 27007485
[TBL] [Abstract][Full Text] [Related]
4. "Non-classical" paraneoplastic neurological syndromes associated with well-characterized antineuronal antibodies as compared to "classical" syndromes - More frequent than expected.
Berger B; Bischler P; Dersch R; Hottenrott T; Rauer S; Stich O
J Neurol Sci; 2015 May; 352(1-2):58-61. PubMed ID: 25824848
[TBL] [Abstract][Full Text] [Related]
5. [Pathogenesis of paraneoplastic neurological syndromes].
Tanaka K
Brain Nerve; 2010 Apr; 62(4):309-18. PubMed ID: 20420170
[TBL] [Abstract][Full Text] [Related]
6. FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes.
Younes-Mhenni S; Janier MF; Cinotti L; Antoine JC; Tronc F; Cottin V; Ternamian PJ; Trouillas P; Honnorat J
Brain; 2004 Oct; 127(Pt 10):2331-8. PubMed ID: 15361417
[TBL] [Abstract][Full Text] [Related]
7. Immunophenotypical characterization of paraneoplastic neurological syndrome patients: a multicentric study.
Lorusso L; Precone V; Hart IK; Giometto B; Pezzani R; Ngonga GK; Ngonga GKNK; Paolacci S; Ferrari D; Ricevuti G; Marshall E; Bertelli M
J Biosci; 2021; 46():. PubMed ID: 33709965
[TBL] [Abstract][Full Text] [Related]
8. Specific antibody index in cerebrospinal fluid from patients with central and peripheral paraneoplastic neurological syndromes.
Stich O; Jarius S; Kleer B; Rasiah C; Voltz R; Rauer S
J Neuroimmunol; 2007 Feb; 183(1-2):220-4. PubMed ID: 17229470
[TBL] [Abstract][Full Text] [Related]
9. Paraneoplastic neurological syndromes - patients' cohort profile in the Czech Republic.
Stourac P; Kadanka Z; Palyza V
Acta Neurol Scand; 2001 Aug; 104(2):72-7. PubMed ID: 11493221
[TBL] [Abstract][Full Text] [Related]
10. Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies.
Ariño H; Höftberger R; Gresa-Arribas N; Martínez-Hernández E; Armangue T; Kruer MC; Arpa J; Domingo J; Rojc B; Bataller L; Saiz A; Dalmau J; Graus F
JAMA Neurol; 2015 Aug; 72(8):874-81. PubMed ID: 26099072
[TBL] [Abstract][Full Text] [Related]
11. Enzyme linked immunosorbent assay using recombinant HuD-autoantigen for serodiagnosis of paraneoplastic neurological syndromes.
Rauer S; Kaiser R
Acta Neurol Scand; 2001 Apr; 103(4):248-54. PubMed ID: 11328197
[TBL] [Abstract][Full Text] [Related]
12. B and T cell imbalances in CSF of patients with Hu-antibody associated PNS.
de Graaf M; de Beukelaar J; Bergsma J; Kraan J; van den Bent M; Klimek M; van Norden Y; Kusuma A; Smitt PS; Gratama JW
J Neuroimmunol; 2008 Mar; 195(1-2):164-70. PubMed ID: 18358542
[TBL] [Abstract][Full Text] [Related]
13. Anti-Ma and anti-Ta associated paraneoplastic neurological syndromes: 22 newly diagnosed patients and review of previous cases.
Hoffmann LA; Jarius S; Pellkofer HL; Schueller M; Krumbholz M; Koenig F; Johannis W; la Fougere C; Newman T; Vincent A; Voltz R
J Neurol Neurosurg Psychiatry; 2008 Jul; 79(7):767-73. PubMed ID: 18223018
[TBL] [Abstract][Full Text] [Related]
14. Intrathecal synthesis of anti-Hu antibodies distinguishes patients with paraneoplastic peripheral neuropathy and encephalitis.
Schwenkenbecher P; Chacko LP; Wurster U; Pars K; Pul R; Sühs KW; Stangel M; Skripuletz T
BMC Neurol; 2016 Aug; 16(1):136. PubMed ID: 27515847
[TBL] [Abstract][Full Text] [Related]
15. [Paraneoplastic neurological syndromes in 2008].
Honnorat J
Rev Neurol (Paris); 2009 May; 165 Suppl 3():S59-65. PubMed ID: 19524096
[TBL] [Abstract][Full Text] [Related]
16. [Paraneoplastic neurologic syndromes: laboratory diagnostics and immunological aspects].
Hayden Z; Böröcz K; Csizmadia Z; Kellermayer Z; Balogh P; Berki T
Magy Onkol; 2019 Sep; 63(3):261-267. PubMed ID: 31533147
[TBL] [Abstract][Full Text] [Related]
17. Paraneoplastic neurological syndromes with onconeural antibodies: A single center retrospective study.
Oliveira V; Videira G; Samões R; Carneiro P; Neves E; Santos E
J Neurol Sci; 2020 Nov; 418():117103. PubMed ID: 32877801
[TBL] [Abstract][Full Text] [Related]
18. Delayed onset of a second paraneoplastic neurological syndrome in eight patients.
Ducray F; Graus F; Vigliani MC; Antoine JC; Rogemond V; Saiz A; Honnorat J
J Neurol Neurosurg Psychiatry; 2010 Aug; 81(8):937-9. PubMed ID: 20562403
[TBL] [Abstract][Full Text] [Related]
19. [Neurological syndromes, encephalitis].
Yamamoto T; Tsuji S
Gan To Kagaku Ryoho; 2010 Jun; 37(6):995-1005. PubMed ID: 20567100
[TBL] [Abstract][Full Text] [Related]
20. Elevated numbers of regulatory T cells, central memory T cells and class-switched B cells in cerebrospinal fluid of patients with anti-Hu antibody associated paraneoplastic neurological syndromes.
de Jongste AH; de Graaf MT; van den Broek PD; Kraan J; Smitt PA; Gratama JW
J Neuroimmunol; 2013 May; 258(1-2):85-90. PubMed ID: 23566401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
